Nuwellis names Mike McCormick CEO, effective June 30, 2026

NUWELLIS INC

NUWELLIS INC

NUWE

0.00
  • Nuwellis named Mike McCormick chief executive officer, effective June 30, 2026.
  • John Erb will step down as president and CEO on June 30, 2026, retaining his role as chairman.
  • McCormick has more than 30 years in medical technology across product development, commercialization, corporate strategy, and value creation.
  • He previously served as a Nuwellis board member and independent director from June 2023 to January 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-025614), on June 18, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.